Neurobiological correlates of auditory processing in health and disease: an RDoC study

健康和疾病中听觉处理的神经生物学相关性:一项 RDoC 研究

基本信息

项目摘要

 DESCRIPTION (provided by applicant): This proposal focuses on the role of auditory perception, a subconstruct within the cognitive systems domain of the Research Domain Criteria (RDoC), in the pathophysiology of auditory perceptual disturbances in health and across traditional (DSM-IV and DSM-V) disease categories. The overall aim is to characterize the neurobiological and neurocomputational basis of auditory sensory learning to identify pathophysiological mechanisms leading to auditory perceptual disturbances and, specifically, auditory verbal hallucinations (AVH). We aim to recruit the following groups: schizophrenia and schizoaffective disorder with low- and high-severity AVH (n=15 and n=15, respectively), delusional disorder (delusional psychosis without AVH; n=15), tinnitus (auditory perceptual disturbances without AVH; n=15), and matched healthy controls (varying degrees of subclinical perceptual disturbances; n=30). We will obtain extensive clinical, neurocognitive, and genetic characterization, and multimodal imaging in all subjects: (1) PET measures of D2/3 receptors and DA storage/release capacity within the thalamus, striatum, and the midbrain, using [11C]PHNO and the amphetamine paradigm; (2) Model-based fMRI measures of sensory prediction-error signals in auditory regions during a probabilistic, auditory discrimination task; 3) MR spectroscopy measures of glutamate concentration in the auditory cortex; (4) Task-based and resting- state fMRI connectivity measures in sensory thalamo-cortical projections; (5) Whole genome sequencing based on blood DNA samples. We will test in the overall sample across diagnostic groups if auditory PE deficits predict AVH (SA1) and correlate with altered DA in striatum and thalamus (SA2) and with increased glutamate in the auditory cortex (SA3). We will also explore the relationship within the same subjects between DA and glutamate (EA1) and the relationships of auditory PE to connectivity between auditory thalamus and auditory cortex (EA2) and identify a set of candidate genes associated with auditory PE deficits (EA3). This RDoC proposal will lead to further understanding of the mechanisms of sensory learning and their perturbations in conditions associated with auditory perceptual alterations.
 描述(由申请人提供):本提案侧重于听觉感知,这是研究领域标准(RDoC)认知系统领域内的一个子结构,在健康和传统(DSM-IV和DSM-V)疾病类别中听觉知觉障碍的病理生理学中的作用。总体目标是表征听觉感觉学习的神经生物学和神经计算基础,以确定导致听觉知觉障碍的病理生理机制,特别是听觉言语幻觉(AVH)。我们的目标是招募以下组:精神分裂症和分裂情感障碍伴轻度和高度AVH(n=15),妄想性障碍(无AVH的妄想性精神病;n=15),耳鸣(无AVH的听觉知觉障碍;n=15),以及匹配的健康对照组(不同程度的亚临床知觉障碍;n=30)。我们将获得所有受试者的广泛的临床、神经认知和遗传特征,以及多模式成像:(1)使用[11C]PHNO和苯丙胺范式,对丘脑、纹状体和中脑内的D2/3受体和DA的储存/释放能力进行PET测量;(2)基于模型的功能磁共振测量(FMRI)测量在概率的听觉辨别任务期间听觉区域的感觉预测错误信号;(3)磁共振波谱测量听觉皮质中的谷氨酸浓度;(4)基于任务和休息状态的功能磁共振测量感觉丘脑皮质的连通性;(5)基于血DNA样本的全基因组测序。我们将在所有诊断组的总体样本中测试听觉PE缺陷是否预测AVH(SA1),并与纹状体和丘脑DA改变(SA2)和听觉皮质谷氨酸增加(SA3)相关。我们还将探索同一受试者中DA和谷氨酸(EA1)之间的关系,以及听觉PE与听觉丘脑和听觉皮质(EA2)之间连接的关系,并确定一组与听觉PE缺陷(EA3)相关的候选基因。RDoC的这一建议将导致对感觉学习的机制及其在与听觉知觉变化相关的条件下的扰动的进一步理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anissa Abi-Dargham其他文献

Anissa Abi-Dargham的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anissa Abi-Dargham', 18)}}的其他基金

Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia
深度 rTMS 调节精神分裂症患者的岛叶突触密度和吸烟行为
  • 批准号:
    10710181
  • 财政年份:
    2022
  • 资助金额:
    $ 73.25万
  • 项目类别:
Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia
深度 rTMS 调节精神分裂症患者的岛叶突触密度和吸烟行为
  • 批准号:
    10494515
  • 财政年份:
    2022
  • 资助金额:
    $ 73.25万
  • 项目类别:
Preliminary imaging studies of the kappa opioid receptors in schizophrenia and their relationship to dopamine function
精神分裂症κ阿片受体及其与多巴胺功能关系的初步影像学研究
  • 批准号:
    10304170
  • 财政年份:
    2020
  • 资助金额:
    $ 73.25万
  • 项目类别:
Probing dopamine D2 receptor trafficking in schizophrenia
探索精神分裂症中的多巴胺 D2 受体贩运
  • 批准号:
    8712557
  • 财政年份:
    2013
  • 资助金额:
    $ 73.25万
  • 项目类别:
Probing dopamine D2 receptor trafficking in schizophrenia
探索精神分裂症中的多巴胺 D2 受体贩运
  • 批准号:
    8584066
  • 财政年份:
    2013
  • 资助金额:
    $ 73.25万
  • 项目类别:
RC2 Alcohol-induced human striatal dopamine release related to alcoholism vulnera
RC2 酒精诱导的人纹状体多巴胺释放与酒精中毒伤病相关
  • 批准号:
    8128248
  • 财政年份:
    2011
  • 资助金额:
    $ 73.25万
  • 项目类别:
Dopamine Dysfunction in Schizophrenia
精神分裂症的多巴胺功能障碍
  • 批准号:
    8102708
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Dopamine Dysfunction in Schizophrenia
精神分裂症的多巴胺功能障碍
  • 批准号:
    8448257
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Dopamine Dysfunction in Schizophrenia
精神分裂症的多巴胺功能障碍
  • 批准号:
    7940012
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Dopamine Dysfunction in Schizophrenia
精神分裂症的多巴胺功能障碍
  • 批准号:
    8249495
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:

相似海外基金

Relationship between neurotoxicity and the chemical structures of amphetamines
安非他明的神经毒性与化学结构的关系
  • 批准号:
    25860103
  • 财政年份:
    2013
  • 资助金额:
    $ 73.25万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for protein expression in amphetamines treated mouse heart : Challenge to the diagnosis for the sudden death of amphetamines abusers
寻找安非他明治疗小鼠心脏中的蛋白质表达:对安非他明滥用者猝死诊断的挑战
  • 批准号:
    22659138
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8312648
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8531900
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8715749
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8144930
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Translational Genetics and Dopamine Signaling in Sensitivity to Amphetamines
安非他明敏感性中的转化遗传学和多巴胺信号传导
  • 批准号:
    7675601
  • 财政年份:
    2009
  • 资助金额:
    $ 73.25万
  • 项目类别:
Simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates and interaction in the rat
大鼠体内麻黄碱、安非他明、可卡因、可卡因代谢物和阿片类药物的同时测定及其相互作用
  • 批准号:
    17590585
  • 财政年份:
    2005
  • 资助金额:
    $ 73.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study for practical use of two chiral analyses of amphetamines by gas chromatography-mass spectrometry
气相色谱-质谱法对苯丙胺两种手性分析的实用化研究
  • 批准号:
    17590588
  • 财政年份:
    2005
  • 资助金额:
    $ 73.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
3,4-亚甲二氧基安非他明的临床药理学
  • 批准号:
    6870119
  • 财政年份:
    2004
  • 资助金额:
    $ 73.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了